We have provided evidence that CEA−/lo CRC cells, which preexist in the tumors, are molecularly and functionally distinct from CEA+ cells and positively correlate with tumor grade and poor prognosis. The gene discussed is CEACAM5; the disease is colorectal carcinoma.